<DOC>
	<DOCNO>NCT01373450</DOCNO>
	<brief_summary>This four-period crossover study assess glycemic effect single dose oxyntomodulin ( OXM ) glucose level participant Type 2 diabetes mellitus ( T2DM ) . Participants randomly assign 1 6 treatment sequence consist 4 treatment period , 7-day wash-out treatment period . The primary hypothesis grade glucose infusion ( GGI ) oxyntomodulin ( OXM ) neutral good placebo ( Pbo ) lower ambient plasma glucose level , significantly enhance insulin secretion .</brief_summary>
	<brief_title>Evaluation Glucoregulatory Effects Glucagon-like Peptide-1 Receptor ( GLP-1 Receptor ) Activation Participants With Type 2 Diabetes Mellitus ( MK-0000-222 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Have body mass index ( BMI ) ≤38.0 kg/m^2 Have clinical diagnosis Type 2 diabetes mellitus Have glycated hemoglobin ( HbA1C ) screen ≤9.0 % ; fast plasma glucose exceed 300 mg/dL ( 16.8 mmol/L ) Judged good health Have history illness , opinion study investigator , might confound result study pose additional risk subject participation study Have history stroke , chronic seizure , major neurological disorder , clinically significant endocrine , cardiovascular , hematological , hepatic , renal , respiratory , genitourinary abnormality disease Have untreated hypertension blood pressure &gt; 160/95 mmHg Have history neoplastic disease within past 5 year Have history hypersensitivity OXM , liraglutide , insulin Haemaccel® Unable unwilling comply restriction around concomitant medication Consume excessive amount alcohol , coffee , tea , cola , caffeinated beverage daily Have major surgery , donate lose 1 unit blood ( approximately 500 mL ) participate another investigational study within 4 week Have history significant multiple and/or severe allergy , anaphylactic reaction significant intolerability prescription nonprescription drug food Currently regular user ( include use illicit drug history drug ( include alcohol ) abuse within approximately 3 month Are unwilling unable consume standardize meal study and/or carbohydrate restrict diet ( i.e. , diet &lt; 100 gram per day carbohydrate )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>